Antidepressant discontinuation worsens postpartum psychiatric outcomes: JAMA
A study published in the Journal of American Medical Association suggests that women with severe mental illness who are currently on stable treatment may benefit from continuing antidepressant treatment and personalized treatment counseling during pregnancy.
Approximately half of women with affective disorders discontinue antidepressant use during pregnancy, but discontinuation can increase the risk of postpartum relapse. This cohort study led by Nhung Trinh investigated the associations between longitudinal antidepressant fill trajectories during pregnancy and postpartum psychiatric outcomes.
The study included 57,934 pregnancies from Denmark and Norway, where the sample consisted of women who had filled at least one antidepressant prescription within 6 months before pregnancy. Antidepressant prescription fills were obtained from prescription registers, and antidepressant treatment during pregnancy was modeled using the k-means longitudinal method. The main outcomes measured were initiation of psycholeptics, psychiatric emergencies, or records of self-harm within one year postpartum.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.